Abstract
The gastrointestinal tract has a crucial role in the control of energy homeostasis through the action of multiple peptides known as incretins that act on distant target sites to promote the efficient uptake and storage of energy. In particular, GLP-1, an incretin hormone secreted from the intestinal mucosa in response to meal ingestion, is shown to augment the magnitude of meal-stimulated insulin secretion from islet β cells in a glucose-dependent manner and thus proved to be a novel candidate for treatment in patients with diabetes mellitus. This article reviews the biological actions of GLP-1 regulating glucose homeostasis, with an emphasis on mechanisms of action and the emerging therapeutic roles of GLP-1 analogues, and DPP-4 inhibitors for the treatment of diabetes mellitus.
Keywords: GLP-1 analogues, DPP-4 Inhibitors, diabetes mellitus
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Title: GLP-1 as a Therapeutic Agent in Patients with Type 2 Diabetes Mellitus
Volume: 1 Issue: 3
Author(s): Ioannis Legakis
Affiliation:
Keywords: GLP-1 analogues, DPP-4 Inhibitors, diabetes mellitus
Abstract: The gastrointestinal tract has a crucial role in the control of energy homeostasis through the action of multiple peptides known as incretins that act on distant target sites to promote the efficient uptake and storage of energy. In particular, GLP-1, an incretin hormone secreted from the intestinal mucosa in response to meal ingestion, is shown to augment the magnitude of meal-stimulated insulin secretion from islet β cells in a glucose-dependent manner and thus proved to be a novel candidate for treatment in patients with diabetes mellitus. This article reviews the biological actions of GLP-1 regulating glucose homeostasis, with an emphasis on mechanisms of action and the emerging therapeutic roles of GLP-1 analogues, and DPP-4 inhibitors for the treatment of diabetes mellitus.
Export Options
About this article
Cite this article as:
Legakis Ioannis, GLP-1 as a Therapeutic Agent in Patients with Type 2 Diabetes Mellitus, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2007; 1 (3) . https://dx.doi.org/10.2174/187221407782409107
DOI https://dx.doi.org/10.2174/187221407782409107 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Pleiotropic Effects of Statins - Clinical Evidence
Current Pharmaceutical Design Brachial-Ankle Pulse Wave Velocity as a Novel Measure of Arterial Stiffness: Present Evidences and Perspectives
Current Hypertension Reviews Evaluation of Glucose and Lipid Lowering Activity of Arganimide A in Normal and Streptozotocin-Induced Diabetic Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook
Current Drug Targets A Review of Cardiogenic Shock in Acute Myocardial Infarction
Current Cardiology Reviews Retinal Protein O-GlcNAcylation and the Ocular Renin-angiotensin System: Signaling Cross-roads in Diabetic Retinopathy
Current Diabetes Reviews Future Anti-aldosterone Agents
Current Pharmaceutical Design Current and Future Therapeutic Strategies in NAFLD
Current Pharmaceutical Design MicroRNAs in the Diagnosis and Treatment of Unstable Angina
Current Topics in Medicinal Chemistry Mass Spectrometry in Doping Control Analysis
Current Organic Chemistry Oxidative-Nitrosative Stress as a Contributing Factor to Cardiovascular Disease in Subjects with Diabetes
Current Vascular Pharmacology Lipoprotein(a) Management: Pharmacological and Apheretic Treatment
Current Medicinal Chemistry Micro RNA: An Epigenetic Regulator of Type 2 Diabetes
MicroRNA Clinical Presentation, Diagnostic Work-Up, and Treatment of Coronary In-Stent Restenosis
Vascular Disease Prevention (Discontinued) Risk Factors for Myocardial Infarction in Women and Men: A Review of the Current Literature
Current Pharmaceutical Design Interaction of Anthocyanins with Drug-metabolizing and Antioxidant Enzymes
Current Medicinal Chemistry A Comprehensive Review on Perfusion Method Development for Bone Marrow Collection and Stem Cell Transplantation
Current Stem Cell Research & Therapy Leptin and the Ob-Receptor as Anti-Obesity Target: Recent In Silico Advances in the Comprehension of the Protein-Protein Interaction and Rational Drug Design of Anti- Obesity Lead Compounds
Current Pharmaceutical Design Potential Anti-cancer Drugs Commonly Used for Other Indications
Current Cancer Drug Targets The Metabolic Treatment of Patients with Coronary Artery Disease: Effects on Quality of Life and Effort Angina
Current Pharmaceutical Design